KKRC

Kohlberg Kravis Roberts & Co’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Kohlberg Kravis Roberts & Co’s Portfolio CHRS Stock Details CHRS Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$2.17M	Hold	3,036,076	–	–	0.04%	33
2025 Q1	$2.41M	Hold	3,036,076	–	–	0.05%	35
2024 Q4	$4.15M	Hold	3,036,076	–	–	0.11%	28
2024 Q3	$3.12M	Hold	3,036,076	–	–	0.04%	38
2024 Q2	$5.25M	Hold	3,036,076	–	–	0.16%	32
2024 Q1	$7.26M	Hold	3,036,076	–	–	0.19%	27
2023 Q4	$10.1M	Hold	3,036,076	–	–	0.3%	27
2023 Q3	$11.4M	Hold	3,036,076	–	–	0.4%	25
2023 Q2	$13M	Hold	3,036,076	–	–	0.4%	23
2023 Q1	$20.8M	Hold	3,036,076	–	–	0.63%	19
2022 Q4	$24M	Hold	3,036,076	–	–	0.81%	18
2022 Q3	$29.2M	Hold	3,036,076	–	–	0.59%	17
2022 Q2	$22.6M	Hold	3,036,076	–	–	0.3%	22
2022 Q1	$39.2M	Hold	3,036,076	–	–	0.36%	18
2021 Q4	$48.5M	Hold	3,036,076	–	–	0.27%	15
2021 Q3	$48.8M	Hold	3,036,076	–	–	0.24%	19
2021 Q2	$42M	Hold	3,036,076	–	–	0.17%	23
2021 Q1	$44.4M	Hold	3,036,076	–	–	0.22%	24
2020 Q4	$52.8M	Hold	3,036,076	–	–	0.27%	26
2020 Q3	$55.7M	Hold	3,036,076	–	–	0.32%	24
2020 Q2	$54.2M	Hold	3,036,076	–	–	0.33%	17
2020 Q1	$49.2M	Sell	3,036,076 -18,979	-0.6%	-$308K	0.31%	14
2019 Q4	$55M	Hold	3,055,055	–	–	0.27%	18
2019 Q3	$61.9M	Hold	3,055,055	–	–	0.35%	16
2019 Q2	$67.5M	Hold	3,055,055	–	–	0.83%	16
2019 Q1	$41.7M	Hold	3,055,055	–	–	0.63%	18
2018 Q4	$27.6M	Hold	3,055,055	–	–	0.5%	24
2018 Q3	$50.4M	Hold	3,055,055	–	–	0.57%	22
2018 Q2	$42.8M	Hold	3,055,055	–	–	0.49%	19
2018 Q1	$33.8M	Hold	3,055,055	–	–	0.41%	17
2017 Q4	$26.9M	Hold	3,055,055	–	–	0.26%	27
2017 Q3	$40.8M	Hold	3,055,055	–	–	0.47%	22
2017 Q2	$43.8M	Hold	3,055,055	–	–	0.5%	19
2017 Q1	$64.6M	Hold	3,055,055	–	–	1.16%	11
2016 Q4	$86M	Hold	3,055,055	–	–	1.37%	9
2016 Q3	$81.8M	Hold	3,055,055	–	–	1.02%	10
2016 Q2	$51.6M	Buy	+3,055,055	New	+$51.6M	0.54%	20
2015 Q1	–	Sell	-3,055,055	Closed	-$49.9M	–	87
2014 Q4	$49.9M	Buy	+3,055,055	New	+$49.9M	0.65%	10